Cargando…
Nanomedicine sheds new light on cancer immunotherapy
Cancer immunotherapy comprising of immune checkpoint blockade (ICB) therapy, immune cell therapies, cancer vaccines and many others represents a profound arsenal in the fight against different types of cancers. However, their overall clinical objective response rates, particularly against most solid...
Autores principales: | Yu, Yingying, Feng, Liangzhu, Liu, Zhuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471084/ https://www.ncbi.nlm.nih.gov/pubmed/37724084 http://dx.doi.org/10.1515/mr-2023-0005 |
Ejemplares similares
-
Light-responsive nanomedicine for cancer immunotherapy
por: Kang, Weirong, et al.
Publicado: (2023) -
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022) -
Dacrycarpus pattern shedding new light on the early floristic exchange between Asia and Australia
por: Wu, Xinkai, et al.
Publicado: (2019) -
Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020) -
Patient-Derived iPSCs and iNs—Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases
por: Tang, Bor Luen
Publicado: (2018)